Based on this, a Rapid Assessment Protocol (RAP) to assess the barriers to diabetes care in LICs was developed by the International Insulin Foundation (IIF: UK registered charity active in the area of health systems and access to diabetes care) with the aim to assess the barriers to access to diabetes care and medicines [7]. The gene discussed is INS; the disease is diabetes mellitus.